CDKL5 kinase controls transcription-coupled responses to DNA damage

Area of Science:

• Molecular Biology
• Genetics
• Neuroscience

Background:

• Mutations in the CDKL5 gene are a primary cause of childhood epilepsy and CDKL5 deficiency disorder (CDD).
• The precise cellular functions and nuclear substrates of CDKL5 remain largely uncharacterized.
• Understanding CDKL5's role is crucial for developing therapeutic strategies for related neurodevelopmental disorders.

Purpose of the Study:

• To investigate the nuclear functions of CDKL5, particularly its role at sites of DNA damage.
• To identify novel nuclear substrates and phosphorylation targets of CDKL5.
• To elucidate the regulatory mechanisms controlling CDKL5 activity in response to DNA damage.

Main Methods:

• Quantitative phosphoproteomics to identify nuclear CDKL5 substrates.
• Cellular assays to track recruitment of CDKL5 and its targets to DNA damage sites.
• Biochemical experiments to assess the role of transcription and poly(ADP-ribose) (PAR) in CDKL5 recruitment and activity.

Main Results:

• CDKL5 is recruited to actively transcribed regions of the nucleus following DNA damage.
• Elongin A (ELOA) was identified as a nuclear substrate phosphorylated by CDKL5 at a specific motif.
• CDKL5 recruitment and ELOA phosphorylation depend on active transcription and PAR synthesis, with CDKL5 binding to PAR.
• CDKL5 kinase activity is essential for silencing genes upregulated by DNA double-strand breaks.

Conclusions:

• CDKL5 functions as a DNA damage-sensing transcriptional modulator within the cell nucleus.
• Its activity is regulated by poly(ADP-ribose) (PAR) and is linked to active transcription.
• These findings provide a molecular basis for CDKL5 deficiency disorder and suggest new avenues for therapeutic intervention.